Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population
- 11 May 2007
- journal article
- Published by BMJ in Journal of Medical Genetics
- Vol. 44 (9) , 606-608
- https://doi.org/10.1136/jmg.2006.048470
Abstract
The gene for insulin-degrading enzyme (IDE), which is located at chromosome 10q24, has been previously proposed as a candidate gene for late-onset Alzheimer’s disease (AD) based on its ability to degrade amyloid β-protein. Genotyping of single nucleotide polymorphisms (SNPs) in the IDE gene in Finnish patients with AD and controls revealed SNPs rs4646953 and rs4646955 to be associated with AD, conferring an approximately two-fold increased risk. Single locus findings were corroborated by the results obtained from haplotype analyses. This suggests that genetic alterations in or near the IDE gene may increase the risk for developing AD.Keywords
This publication has 9 references indexed in Scilit:
- Insulin-degrading enzyme and Alzheimer diseaseNeurology, 2004
- Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-ProteinThe American Journal of Pathology, 2004
- Genetic variation in a haplotype block spanningIDE influences Alzheimer diseaseHuman Mutation, 2003
- Susceptibility Locus for Alzheimer's Disease on Chromosome 10Science, 2000
- Linkage of Plasma Aβ42 to a Quantitative Locus on Chromosome 10 in Late-Onset Alzheimer's Disease PedigreesScience, 2000
- Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10qScience, 2000
- Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by DegradationJournal of Biological Chemistry, 1998
- Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's diseaseNeurology, 1996
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984